Home Page > ANTIBODY > POLYCLONAL ANTIBODY > Goat Polyclonal Antibodies >  Goat anti-CDK9 Antibody

Goat anti-CDK9 Antibody
Item#:
dAP-3470
Size Price Quantity
50.0 ug $310.00
Goat anti-CDK9 Antibody
Principle Name CDK9
Official Symbol CDK9
All Name and Symbols CDK9; cyclin-dependent kinase 9; C-2k; CDC2L4; CTK1; PITALRE; TAK; CDC2-related kinase; cell division cycle 2-like protein kinase 4; cell division protein kinase 9; serine/threonine protein kinase PITALRE; tat-associated kinase complex catalytic subunit
Accession Number(s) NP_001252.1
Peptide Sequence KGSQITQQSTNQSRN, is from C Terminus
Human Gene ID(s) 1025
Non-Human GeneID(s) 107951 (mouse); 362110 (rat);
Important Comments
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied As lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
Applications Pep ELISA, WB
Tested Species Mouse
Peptide ELISA antibody detection limit dilution 1 to 8000.
Western Blot Approx 40-45kDa band observed in nuclear cell lysates of NIH3T3 (calculated MW of 42.8kDa according to Mouse NP_570930.1). Recommended concentration
Reference(s) Yin T, Lallena MJ, Kreklau EL, Fales KR, Carballares S, Torrres R, Wishart GN, Ajamie RT, Cronier DM, Iversen PW, Meier TI, Foreman RT, Zeckner D, Sissons SE, Halstead BW, Lin AB, Donoho GP, Qian Y, Li S, Wu S, Aggarwal A, Ye XS, Starling JJ, Gaynor RB, d A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models. Molecular cancer therapeutics 2014 Jun 13 (6)

ANGIO-PROTEOMIE, ALL RIGHTS RESERVED